Zacks Investment ResearchMon, 04 May 2026 15:06:22 GMTWill Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should KnowAQST+2.13%
Seeking AlphaWed, 11 Mar 2026 06:46:47 GMTAquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA ApprovalAQST+2.13%
Seeking AlphaThu, 05 Mar 2026 18:15:55 GMTAquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call TranscriptAQST+2.13%
Zacks Investment ResearchThu, 05 Mar 2026 00:30:12 GMTCompared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key MetricsAQST+2.13%
Zacks Investment ResearchWed, 04 Mar 2026 23:16:10 GMTAquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue EstimatesAQST+2.13%
Seeking AlphaTue, 17 Feb 2026 20:15:33 GMTAquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRLAQST+2.13%
